Wavepaths builds on scientific research showing the critical role of music in psychedelic therapy, offering clinicians an AI-powered system that generates personalized, adaptive soundscapes in real time. Practitioners can seamlessly shift emotional atmospheres, depth, activation levels and instrumentation, drawing on compositions from artists such as Jon Hopkins, Greg Haines, Robert Rich and Christina Vantzou. Founded in 2019 by Dr. Mendel Kaelen and Anna Rickman, the company partners with research institutions, universities and psychedelic-therapy providers to study and optimize therapeutic outcomes. The product is currently in closed beta, is used in more than 29 countries and has a wait-list exceeding 5,000 practitioners ahead of a planned public launch later this year. Fresh capital will be deployed to refine the platform’s personalization and music-generation algorithms, scale infrastructure and add features for a broader range of healthcare practices.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2021